Molecular pathology of low malignant bladder 
transitional cell carcinoma: a current perspective

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10201/22445

RefMan EndNote BibTex RefWorks Excel CSV PDF Mendeley

Registro completo de metadatos

Campo DC	Valor	Lengua/Idioma
dc.contributor.author	Wang, H.T.	es
dc.contributor.author	Chang, J.W.	es
dc.date.accessioned	2011-06-30T11:59:51Z	-
dc.date.available	2011-06-30T11:59:51Z	-
dc.date.issued	2005	-
dc.identifier.issn	0213-3911	es
dc.identifier.uri	http://hdl.handle.net/10201/22445	-
dc.description.abstract	Bladder transitional cell carcinoma (BTCC) actually has two phenotypes: low malignant and aggressive. Most previous molecular and cytogenetic analyses of bladder cancer were focused on aggressive BTCC. Little is known about the events that lead to the development of low malignant BTCC. This review mainly introduces the concept of two types of bladder tumors and then focuses on the molecular pathology of low malignant BTCC in particular. It is hoped that further understanding of the molecular pathology of low malignant BTCC may provide novel therapies and many other clinical benefits in patients with this disease.	es
dc.format	application/pdf	es
dc.format.extent	7	es
dc.language	eng	es
dc.publisher	Murcia : F. Hernández	es
dc.relation.ispartof	Histology and histopathology	es
dc.rights	info:eu-repo/semantics/openAccess	es
dc.subject	Bladder cancer	es
dc.subject	Oncogene	es
dc.subject.other	CDU::6 - Ciencias aplicadas::61 - Medicina	es
dc.title	Molecular pathology of low malignant bladder transitional cell carcinoma: a current perspective	es
dc.type	info:eu-repo/semantics/article	es
Aparece en las colecciones:	Vol.20, nº 1 (2005)

Ficheros en este ítem:

Fichero	Descripción	Tamaño	Formato
Molecular pathology of low malignant bladder.pdf		413,95 kB	Adobe PDF	Visualizar/Abrir